228 related articles for article (PubMed ID: 9208176)
1. Stereoselective activation of dibenzo[a,l]pyrene and its trans-11,12-dihydrodiol to fjord region 11,12-diol 13,14-epoxides in a human mammary carcinoma MCF-7 cell-mediated V79 cell mutation assay.
Ralston SL; Coffing SL; Seidel A; Luch A; Platt KL; Baird WM
Chem Res Toxicol; 1997 Jun; 10(6):687-93. PubMed ID: 9208176
[TBL] [Abstract][Full Text] [Related]
2. Stable expression of human cytochrome P450 1B1 in V79 Chinese hamster cells and metabolically catalyzed DNA adduct formation of dibenzo[a,l]pyrene.
Luch A; Coffing SL; Tang YM; Schneider A; Soballa V; Greim H; Jefcoate CR; Seidel A; Greenlee WF; Baird WM; Doehmer J
Chem Res Toxicol; 1998 Jun; 11(6):686-95. PubMed ID: 9625737
[TBL] [Abstract][Full Text] [Related]
3. Metabolic activation of the (+)-S,S- and (-)-R,R-enantiomers of trans-11,12-dihydroxy-11,12-dihydrodibenzo[a,l]pyrene: stereoselectivity, DNA adduct formation, and mutagenicity in Chinese hamster V79 cells.
Luch A; Seidel A; Glatt H; Platt KL
Chem Res Toxicol; 1997 Oct; 10(10):1161-70. PubMed ID: 9348439
[TBL] [Abstract][Full Text] [Related]
4. Metabolic activation of racemic and enantiomeric trans-8, 9-dihydroxy-8,9-dihydrodibenzo[a,l]pyrene (dibenzo[def,p]chrysene) to dibenzo[a,l]pyrene-bis-dihydrodiols by induced rat liver microsomes and a recombinant human P450 1A1 system: the role of the K-region-derived metabolic intermediates in the formation of dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Padgett W; George M; Lambert G; Meyers F; Allison J; Adams L; King LC
Chem Res Toxicol; 1998 Dec; 11(12):1596-607. PubMed ID: 9860506
[TBL] [Abstract][Full Text] [Related]
5. The level of DNA modification by (+)-syn-(11S,12R,13S,14R)- and (-)-anti-(11R,12S,13S,14R)-dihydrodiol epoxides of dibenzo[a,l]pyrene determined the effect on the proteins p53 and p21WAF1 in the human mammary carcinoma cell line MCF-7.
Luch A; Kudla K; Seidel A; Doehmer J; Greim H; Baird WM
Carcinogenesis; 1999 May; 20(5):859-65. PubMed ID: 10334204
[TBL] [Abstract][Full Text] [Related]
6. Stereoselective activation of dibenzo[a,l]pyrene to (-)-anti (11R,12S,13S,14R)- and (+)-syn(11S,12R,13S,14R)-11,12-diol-13,14-epoxides which bind extensively to deoxyadenosine residues of DNA in the human mammary carcinoma cell line MCF-7.
Ralston SL; Seidel A; Luch A; Platt KL; Baird WM
Carcinogenesis; 1995 Dec; 16(12):2899-907. PubMed ID: 8603462
[TBL] [Abstract][Full Text] [Related]
7. The K-region trans-8,9-diol does not significantly contribute as an intermediate in the metabolic activation of dibenzo[a,l]pyrene to DNA-binding metabolites by human cytochrome P450 1A1 or 1B1.
Luch A; Kishiyama S; Seidel A; Doehmer J; Greim H; Baird WM
Cancer Res; 1999 Sep; 59(18):4603-9. PubMed ID: 10493514
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and mutagenicity of the diastereomeric fjord-region 11,12-dihydrodiol 13,14-epoxides of dibenzo[a,l]pyrene.
Luch A; Glatt H; Platt KL; Oesch F; Seidel A
Carcinogenesis; 1994 Nov; 15(11):2507-16. PubMed ID: 7955100
[TBL] [Abstract][Full Text] [Related]
9. Metabolic activation of dibenzo[a,l]pyrene by human cytochrome P450 1A1 and P450 1B1 expressed in V79 Chinese hamster cells.
Luch A; Schober W; Soballa VJ; Raab G; Greim H; Jacob J; Doehmer J; Seidel A
Chem Res Toxicol; 1999 Apr; 12(4):353-64. PubMed ID: 10207125
[TBL] [Abstract][Full Text] [Related]
10. The potent carcinogen dibenzo[a,l]pyrene is metabolically activated to fjord-region 11,12-diol 13,14-epoxides in human mammary carcinoma MCF-7 cell cultures.
Ralston SL; Lau HH; Seidel A; Luch A; Platt KL; Baird WM
Cancer Res; 1994 Feb; 54(4):887-90. PubMed ID: 8313376
[TBL] [Abstract][Full Text] [Related]
11. Cytochrome P450 1B1 determines susceptibility to dibenzo[a,l]pyrene-induced tumor formation.
Buters JT; Mahadevan B; Quintanilla-Martinez L; Gonzalez FJ; Greim H; Baird WM; Luch A
Chem Res Toxicol; 2002 Sep; 15(9):1127-35. PubMed ID: 12230405
[TBL] [Abstract][Full Text] [Related]
12. Formation of stable adducts and absence of depurinating DNA adducts in cells and DNA treated with the potent carcinogen dibenzo[a,l]pyrene or its diol epoxides.
Melendez-Colon VJ; Smith CA; Seidel A; Luch A; Platt KL; Baird WM
Proc Natl Acad Sci U S A; 1997 Dec; 94(25):13542-7. PubMed ID: 9391062
[TBL] [Abstract][Full Text] [Related]
13. Mutations induced by (-)-anti-11R,12S-dihydrodiol 13S,14R-epoxide of dibenzo[a,l]pyrene in the coding region of the hypoxanthine phosphoribosyltransferase (Hprt) gene in Chinese hamster V79 cells.
Mahadevan B; Dashwood WM; Luch A; Pecaj A; Doehmer J; Seidel A; Pereira C; Baird WM
Environ Mol Mutagen; 2003; 41(2):131-9. PubMed ID: 12605383
[TBL] [Abstract][Full Text] [Related]
14. Synthesis and characterization of site-specific and stereoisomeric fjord dibenzo[a,l]pyrene diol epoxide-N(6)-adenine adducts: unusual thermal stabilization of modified DNA duplexes.
Ruan Q; Kolbanovskiy A; Zhuang P; Chen J; Krzeminski J; Amin S; Geacintov NE
Chem Res Toxicol; 2002 Feb; 15(2):249-61. PubMed ID: 11849052
[TBL] [Abstract][Full Text] [Related]
15. DNA damage, repair, and mutation induction by (+)-Syn and (-)-anti-dibenzo[a,l]pyrene-11,12-diol-13,14-epoxides in mouse cells.
Yoon JH; Besaratinia A; Feng Z; Tang MS; Amin S; Luch A; Pfeifer GP
Cancer Res; 2004 Oct; 64(20):7321-8. PubMed ID: 15492252
[TBL] [Abstract][Full Text] [Related]
16. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
[TBL] [Abstract][Full Text] [Related]
17. A quantitative comparison of dibenzo[a,l]pyrene-DNA adduct formation by recombinant human cytochrome P450 microsomes.
King LC; Adams L; Allison J; Kohan MJ; Nelson G; Desai D; Amin S; Ross JA
Mol Carcinog; 1999 Oct; 26(2):74-82. PubMed ID: 10506751
[TBL] [Abstract][Full Text] [Related]
18. Identification and quantification of the depurinating DNA adducts formed in mouse skin treated with dibenzo[a,l]pyrene (DB[a,l]P) or its metabolites and in rat mammary gland treated with DB[a,l]P.
Cavalieri EL; Rogan EG; Li KM; Todorovic R; Ariese F; Jankowiak R; Grubor N; Small GJ
Chem Res Toxicol; 2005 Jun; 18(6):976-83. PubMed ID: 15962932
[TBL] [Abstract][Full Text] [Related]
19. Formation of stable DNA adducts and apurinic sites upon metabolic activation of bay and fjord region polycyclic aromatic hydrocarbons in human cell cultures.
Melendez-Colon VJ; Luch A; Seidel A; Baird WM
Chem Res Toxicol; 2000 Jan; 13(1):10-7. PubMed ID: 10649961
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the morphological transforming activities of dibenzo[a,l]pyrene and benzo[a]pyrene in C3H10T1/2CL8 cells and characterization of the dibenzo[a,l]pyrene-DNA adducts.
Nesnow S; Davis C; Nelson G; Ross JA; Allison J; Adams L; King LC
Carcinogenesis; 1997 Oct; 18(10):1973-8. PubMed ID: 9364008
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]